scholarly journals Cost Effective, Experimentally Robust Differential Expression Analysis for Human/Mammalian, Pathogen, and Dual-Species Transcriptomics

2018 ◽  
Author(s):  
Amol Shetty ◽  
Anup Mahurkar ◽  
Scott Filler ◽  
Claire M. Fraser ◽  
David A. Rasko ◽  
...  

ABSTRACTAs sequencing read length has increased, researchers have quickly adopted longer reads for their experiments. Here, we examine host-pathogen interaction studies to assess if using longer reads is warranted. Six diverse datasets encountered in studies of host-pathogen interactions were used to assess what genomic attributes might affect the outcome of differential gene expression analysis including: gene density, operons, gene length, number of introns/exons, and intron length. Principal components analysis, hierarchical clustering with bootstrap support, and regression analyses of pairwise comparisons were undertaken on the same reads, looking at all combinations of paired and unpaired reads trimmed to 36,54,72, and 101-bp. For E coli, 36-bp single end reads performed as well as any other read length and as well as paired end reads. For all other comparisons, 54-bp and 72-bp reads were typically equivalent and different from 36-bp and 101-bp reads. Read pairing improved the outcome in several, but not all, comparisons in no discernable pattern, such that using paired reads is recommended in most scenarios. No specific genome attribute appeared to influence the data. However, experiments with an a priori expected greater biological complexity had more variable results with all read lengths relative to those with decreased complexity. When combined with cost, 54-bp paired end reads provided the most robust, internally reproducible results across all comparisons. However, using 36-bp single end reads may be desirable for bacterial samples, although possibly only if the transcriptional response is expected a priori to be robust.DATA SUMMARYThe human only CSHL Encode data set (1) was downloaded from ftp://hgdownload.cse.ucsc.edu/goldenPath/hgl9/encodeDCC/wgEncodeCshlLongRnaSeq/.The data from mice vaginas infected with Candida albicans (2) was downloaded from the SRA (url - https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP057050).The data from Aspergillus fumigatus cells in contact with human cells was downloaded from the SRA (url - https://www.ncbi.nlm.nih.gov/bioproject/399754).The data from a strand-specific library from a study comparing C. albicans cells in contact with human cells with those in media (3) was downloaded from the SRA (url - https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP011085).The data from C. albicans in culture media (3) was downloaded from the SRA (url - https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP011085).The data from Escherichia coli grown in different media (4) was downloaded from the SRA (url - https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP056578).I/We confirm all supporting data, code and protocols have been provided within the article or through supplementary data files. ⊠IMPACT STATEMENTAs sequencing technologies improve, sequencing costs decrease and read lengths increase. We examine host-pathogen interaction studies to assess if using these longer reads is warranted given their increased cost relative to using the same number of shorter reads. To this end we compared the use of various read lengths and read pairing for six diverse host-pathogen datasets with varying genomic attributes including: gene density, operons, gene length, number of introns/exons, and intron length. We find that in the bacterial sample, 36-bp single end reads performed as well as any other read length and as well as paired end reads. When combined with cost, 54-bp paired end reads provided the most robust, internally reproducible results for all other comparisons. Read pairing improved the outcome in several, but not all, comparisons in no discernable pattern, such that using paired reads is recommended in most scenarios. No specific genome attribute appeared to influence the data.

Author(s):  
Palaniappan Sethu ◽  
Kalyani Putty ◽  
Yongsheng Lian ◽  
Awdhesh Kalia

A bacterial species typically includes heterogeneous collections of genetically diverse isolates. How genetic diversity within bacterial populations influences the clinical outcome of infection remains mostly indeterminate. In part, this is due to a lack of technologies that can enable contemporaneous systems-level interrogation of host-pathogen interaction using multiple, genetically diverse bacterial strains. This chapter presents a prototype microfluidic cell array (MCA) that allows simultaneous elucidation of molecular events during infection of human cells in a semi-automated fashion. It shows that infection of human cells with up to sixteen genetically diverse bacterial isolates can be studied simultaneously. The versatility of MCAs is enhanced by incorporation of a gradient generator that allows interrogation of host-pathogen interaction under four different concentrations of any given environmental variable at the same time. Availability of high throughput MCAs should foster studies that can determine how differences in bacterial gene pools and concentration-dependent environmental variables affect the outcome of host-pathogen interaction.


2017 ◽  
Vol 148 (3) ◽  
pp. 617-629
Author(s):  
Khaled AlTaweel ◽  
Chami C. Amarasinghe ◽  
Anita L. Brûlé-Babel ◽  
W. G. Dilantha Fernando

2013 ◽  
pp. 745-760
Author(s):  
Palaniappan Sethu ◽  
Kalyani Putty ◽  
Yongsheng Lian ◽  
Awdhesh Kalia

A bacterial species typically includes heterogeneous collections of genetically diverse isolates. How genetic diversity within bacterial populations influences the clinical outcome of infection remains mostly indeterminate. In part, this is due to a lack of technologies that can enable contemporaneous systems-level interrogation of host-pathogen interaction using multiple, genetically diverse bacterial strains. This chapter presents a prototype microfluidic cell array (MCA) that allows simultaneous elucidation of molecular events during infection of human cells in a semi-automated fashion. It shows that infection of human cells with up to sixteen genetically diverse bacterial isolates can be studied simultaneously. The versatility of MCAs is enhanced by incorporation of a gradient generator that allows interrogation of host-pathogen interaction under four different concentrations of any given environmental variable at the same time. Availability of high throughput MCAs should foster studies that can determine how differences in bacterial gene pools and concentration-dependent environmental variables affect the outcome of host-pathogen interaction.


2021 ◽  
Vol 23 (1) ◽  
Author(s):  
Erica M. Stringer-Reasor ◽  
Jori E. May ◽  
Eva Olariu ◽  
Valerie Caterinicchia ◽  
Yufeng Li ◽  
...  

Abstract Background Poly (ADP-ribose)-polymerase inhibitors (PARPi) have been approved for cancer patients with germline BRCA1/2 (gBRCA1/2) mutations, and efforts to expand the utility of PARPi beyond BRCA1/2 are ongoing. In preclinical models of triple-negative breast cancer (TNBC) with intact DNA repair, we have previously shown an induced synthetic lethality with combined EGFR inhibition and PARPi. Here, we report the safety and clinical activity of lapatinib and veliparib in patients with metastatic TNBC. Methods A first-in-human, pilot study of lapatinib and veliparib was conducted in metastatic TNBC (NCT02158507). The primary endpoint was safety and tolerability. Secondary endpoints were objective response rates and pharmacokinetic evaluation. Gene expression analysis of pre-treatment tumor biopsies was performed. Key eligibility included TNBC patients with measurable disease and prior anthracycline-based and taxane chemotherapy. Patients with gBRCA1/2 mutations were excluded. Results Twenty patients were enrolled, of which 17 were evaluable for response. The median number of prior therapies in the metastatic setting was 1 (range 0–2). Fifty percent of patients were Caucasian, 45% African–American, and 5% Hispanic. Of evaluable patients, 4 demonstrated a partial response and 2 had stable disease. There were no dose-limiting toxicities. Most AEs were limited to grade 1 or 2 and no drug–drug interactions noted. Exploratory gene expression analysis suggested baseline DNA repair pathway score was lower and baseline immunogenicity was higher in the responders compared to non-responders. Conclusions Lapatinib plus veliparib therapy has a manageable safety profile and promising antitumor activity in advanced TNBC. Further investigation of dual therapy with EGFR inhibition and PARP inhibition is needed. Trial registration ClinicalTrials.gov, NCT02158507. Registered on 12 September 2014


Pathogens ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 905
Author(s):  
Estela Ruiz-Baca ◽  
Armando Pérez-Torres ◽  
Yolanda Romo-Lozano ◽  
Daniel Cervantes-García ◽  
Carlos A. Alba-Fierro ◽  
...  

The role of immune cells associated with sporotrichosis caused by Sporothrix schenckii is not yet fully clarified. Macrophages through pattern recognition receptors (PRRs) can recognize pathogen-associated molecular patterns (PAMPs) of Sporothrix, engulf it, activate respiratory burst, and secrete pro-inflammatory or anti-inflammatory biological mediators to control infection. It is important to consider that the characteristics associated with S. schenckii and/or the host may influence macrophage polarization (M1/M2), cell recruitment, and the type of immune response (1, 2, and 17). Currently, with the use of new monocyte-macrophage cell lines, it is possible to evaluate different host–pathogen interaction processes, which allows for the proposal of new mechanisms in human sporotrichosis. Therefore, in order to contribute to the understanding of these host–pathogen interactions, the aim of this review is to summarize and discuss the immune responses induced by macrophage-S. schenckii interactions, as well as the PRRs and PAMPs involved during the recognition of S. schenckii that favor the immune evasion by the fungus.


2012 ◽  
Vol 8 (10) ◽  
pp. e1002933 ◽  
Author(s):  
Hanna K. de Jong ◽  
Chris M. Parry ◽  
Tom van der Poll ◽  
W. Joost Wiersinga

Sign in / Sign up

Export Citation Format

Share Document